SpringWorks Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
30 Nov 23 | SellUS$11,419,280 | OrbiMed Advisors LLC | Company | 401,429 | US$32.31 | |
15 May 23 | BuyUS$9,932,875 | OrbiMed Advisors LLC | Company | 320,312 | US$31.01 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,959 | 0.00621% |
Individual Insiders | 1,566,164 | 1.96% |
VC/PE Firms | 4,063,676 | 5.09% |
Institutions | 74,279,695 | 92.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,809,235 | US$494.5m | 15.2% | 0.03% | |||
6,036,542 | US$276.2m | 22.6% | no data | |||
5,382,184 | US$246.2m | 21.6% | no data | |||
4,063,676 | US$185.9m | 14.6% | 5.92% | |||
3,421,541 | US$156.5m | 0% | 8.63% | |||
3,219,359 | US$147.3m | -18.9% | 1.98% | |||
3,024,859 | US$138.4m | 135% | 0.29% | |||
2,873,216 | US$131.4m | 351% | 2.32% | |||
2,776,570 | US$127.0m | 78.5% | 0.01% | |||
2,619,650 | US$119.8m | 1.88% | no data | |||
2,584,376 | US$118.2m | 63.6% | 2.22% | |||
2,169,117 | US$99.2m | 312% | 0.21% | |||
2,096,808 | US$95.9m | -12.5% | 1.05% | |||
1,957,246 | US$89.5m | 28.7% | 1.96% | |||
1,615,348 | US$73.9m | -11.1% | 1.96% | |||
1,558,487 | US$71.3m | 47.9% | 0.05% | |||
1,419,088 | US$64.9m | 20.1% | 0.01% | |||
1,127,755 | US$51.6m | -0.23% | 2.94% | |||
1,016,657 | US$46.5m | 0% | 0.04% | |||
968,405 | US$44.3m | -4.25% | 0.01% | |||
917,275 | US$42.0m | 2.67% | 0.1% | |||
802,182 | US$36.7m | 319% | 0.39% | |||
791,271 | US$36.2m | 2.97% | no data | |||
625,000 | US$28.6m | 0% | 0.48% | |||
591,382 | US$27.1m | 13.5% | no data |